| |
| |
|
| Insider
Information: |
Evans Daron |
| Relationship: |
|
| City: |
Berkeley |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
269,718 |
|
|
Indirect Shares
|
60,269 |
|
|
| Direct
Value |
$765,828 |
|
|
|
Indirect Value
|
$243,046 |
|
|
| Total
Shares |
329,987 |
|
|
| Total
Value |
$1,008,874 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
7
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
7.0
|
0.0
|
| Percentage
Gain/Loss : |
 173.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Capricor Therapeutics |
CAPR |
Chief Financial Officer |
2009-07-07 |
14,152 |
2009-07-07 |
9,600 |
Premium* |
|
|
Nephros Inc |
NEPH |
CEO Specialty Renal Pr... |
2021-05-24 |
134,215 |
2021-05-27 |
8,669 |
Premium* |
|
|
Rezolute, Inc |
RZLT |
|
2024-05-29 |
121,351 |
2024-05-29 |
42,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RZLT |
Rezolute, Inc |
CFO |
• • – |
2024-05-24 |
4 |
B |
$3.23 |
$9,503 |
I/I |
2,942 |
13,000 |
0.01 |
% |
|
| RZLT |
Rezolute, Inc |
CFO |
• • – |
2024-05-29 |
4 |
B |
$3.50 |
$1,579 |
D/D |
451 |
121,351 |
0.01 |
% |
|
| NEPH |
Nephros Inc |
CEO Specialty Renal Products |
• – – |
2021-05-27 |
4/A |
D |
$2.70 |
$1,885 |
I/I |
(698) |
8,669 |
0 |
- |
|
| NEPH |
Nephros Inc |
Director |
– • – |
2013-11-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,500 |
|
- |
|
| RZLT |
Rezolute, Inc |
CFO |
• – – |
2024-01-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,000 |
|
% |
|
| RZLT |
Rezolute, Inc |
CFO |
• – – |
2024-01-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,000 |
|
% |
|
| NEPH |
Nephros Inc |
President and CEO |
• • – |
2018-05-14 |
4 |
OE |
$0.30 |
$12,000 |
I/I |
40,000 |
95,000 |
0 |
- |
|
| NEPH |
Nephros Inc |
CEO of Specialty Renal Product |
• – – |
2021-05-24 |
4 |
OE |
$2.70 |
$5,999 |
I/I |
2,222 |
9,018 |
0 |
- |
|
58 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
